JPH0940601A - Method for producing optically active ketone derivative and optically active ketone derivative - Google Patents
Method for producing optically active ketone derivative and optically active ketone derivativeInfo
- Publication number
- JPH0940601A JPH0940601A JP7212862A JP21286295A JPH0940601A JP H0940601 A JPH0940601 A JP H0940601A JP 7212862 A JP7212862 A JP 7212862A JP 21286295 A JP21286295 A JP 21286295A JP H0940601 A JPH0940601 A JP H0940601A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- alkyl group
- optically active
- ketone derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
(57)【要約】
【課題】本発明は、農医薬中間体として有用な光学活性
ケトン誘導体及びその立体選択的に高収率で、工業的に
有利な製造方法を提供することを目的とするものであ
る。
【解決手段】式〔1〕
【化1】
(式中、R1は水素原子、ハロゲン原子、ニトロ基、ア
ルキル基等を、R2は低級アルキル基又はハロゲン原子
を示す。)で表される化合物と式〔2〕
【化2】
(式中、R3は低級アルキル基又はハロゲン原子を、R4
は低級アルキル基又は低級アルコキシカルボニルメチル
基を示し、*を付した炭素原子は〔R〕−配置又は
〔S〕−配置を有する。)で表される化合物とを反応さ
せることを特徴とする、式〔3〕
【化3】
で表される化合物の製造方法、および式〔4〕
【化4】
(式中、R5はニトロ基、アルキル基 またはフェニル
基を,R6は低級アルキル基を、R7は低級アルコキシカ
ルボニルメチル基を示す。)で表される化合物である。(57) Abstract: An object of the present invention is to provide an optically active ketone derivative useful as an agricultural and pharmaceutical intermediate, and a stereoselectively high yield thereof, and an industrially advantageous production method. It is a thing. SOLUTION: Formula [1] (Wherein R 1 represents a hydrogen atom, a halogen atom, a nitro group, an alkyl group, etc., and R 2 represents a lower alkyl group or a halogen atom) and a compound represented by the formula [2]: (Wherein the R 3 is a lower alkyl group or a halogen atom, R 4
Represents a lower alkyl group or a lower alkoxycarbonylmethyl group, and the carbon atom marked with * has the [R] -configuration or the [S] -configuration. ), A compound represented by the formula [3]: And a method of producing a compound represented by the formula [4] (In the formula, R 5 represents a nitro group, an alkyl group or a phenyl group, R 6 represents a lower alkyl group, and R 7 represents a lower alkoxycarbonylmethyl group.).
Description
【0001】[0001]
【産業上の利用分野】本発明は、光学活性な医薬、農薬
等、例えば、優れた強心作用又は血小板凝集抑制作用を
有する医薬品として有用な、特開平2−56468およ
び特開平6−192098)に記載の式〔5〕BACKGROUND OF THE INVENTION The present invention is disclosed in JP-A-2-56468 and JP-A-6-192098, which are useful as optically active pharmaceutical agents, agricultural chemicals and the like, for example, pharmaceutical agents having an excellent cardiotonic action or platelet aggregation inhibitory action. Formula [5] described
【化5】 で表される光学活性化合物の合成中間体として有用な光
学活性ケトン誘導体の製造方法および光学活性ケトン誘
導体に関する。Embedded image The present invention relates to a method for producing an optically active ketone derivative useful as a synthetic intermediate of an optically active compound represented by and an optically active ketone derivative.
【0002】[0002]
【従来の技術】J.Org.Chem.56,1963
−6(1991) には、アセトアニリドと光学活性な
酸クロリドを用いて光学活性ケトン誘導体を合成する方
法が記載されている。2. Description of the Related Art Org. Chem. 56 , 1963
-6 (1991) describes a method of synthesizing an optically active ketone derivative using acetanilide and an optically active acid chloride.
【0003】[0003]
【化6】 (式中、XはBrまたはClを、r1は水素またはアセ
チル基を、r2,r3は水素、メチル基、ブチル基または
ベンジル基を示す。) しかし、この方法を前記式〔5〕で表される化合物の重
要な中間体である式〔6〕[Chemical 6] (In the formula, X represents Br or Cl, r 1 represents hydrogen or an acetyl group, and r 2 and r 3 represent hydrogen, a methyl group, a butyl group or a benzyl group.) However, this method is represented by the above formula [5]. [6] which is an important intermediate of the compound represented by
【0004】[0004]
【化7】 の光学活性な酸クロリドに応用すると異性化してしま
い、目的化合物である式〔7〕[Chemical 7] When it is applied to the optically active acid chloride of, isomerization occurs, and the target compound of formula [7]
【0005】[0005]
【化8】 は副生成物としてしか得られず、主生成物は異性化した
式〔8〕Embedded image Is obtained only as a by-product, and the main product is isomerized formula [8]
【0006】[0006]
【化9】 であった。また両者を分離することは非常に困難であっ
た。Embedded image Met. Moreover, it was very difficult to separate the two.
【0007】光学非活性の酸クロリドと有機スズ化合物
のカップリング反応は、例えばJ.Am.Chem.S
oc.,113,2319−21(1991)に下記の
反応が記載されているが、光学活性なケトン誘導体にも
適用できるという記載はない。The coupling reaction between an optically inactive acid chloride and an organotin compound is described in, for example, J. Am. Chem. S
oc. , 113 , 2319-21 (1991), the following reaction is described, but there is no description that it is applicable to an optically active ketone derivative.
【0008】[0008]
【化10】 不斉炭素をもつ医薬品の開発は原則として光学活性体で
行われており、光学活性化合物の製造方法の研究は重要
課題となっている。Embedded image As a general rule, the development of pharmaceuticals having an asymmetric carbon is carried out using optically active compounds, and research on methods for producing optically active compounds has become an important issue.
【0009】本発明は、農医薬中間体として有用な光学
活性ケトン誘導体及びその立体選択的に高収率で、工業
的に有利な製造方法を提供することを目的とするもので
ある。It is an object of the present invention to provide an optically active ketone derivative useful as an intermediate for agricultural and pharmaceutical products and a stereoselectively high yield thereof and an industrially advantageous production method.
【0010】本発明は、 1.式〔1〕The present invention includes: Formula [1]
【化11】 (式中、R1 は水素原子、ハロゲン原子、ニトロ基、ア
ルキル基、フェニル基、アルコキシ基又はアルキルチオ
基を、R2 は低級アルキル基又はハロゲン原子を示
す。)で表される化合物と、式〔2〕Embedded image (Wherein R 1 represents a hydrogen atom, a halogen atom, a nitro group, an alkyl group, a phenyl group, an alkoxy group or an alkylthio group, and R 2 represents a lower alkyl group or a halogen atom), and a compound represented by the formula: [2]
【0011】[0011]
【化12】 (式中、R3 は低級アルキル基又はハロゲン原子を、R
4 は低級アルキル基又は低級アルコキシカルボニルメチ
ル基を示し、*を付した炭素原子は〔R〕−配置又は
〔S〕−配置を有する。但しR3 とR4 は同時に同じア
ルキル基ではない。)で表される化合物とを反応させる
ことを特徴とする、式〔3〕[Chemical 12] (In the formula, R 3 is a lower alkyl group or a halogen atom,
4 represents a lower alkyl group or a lower alkoxycarbonylmethyl group, and the carbon atom marked with * has [R] -configuration or [S] -configuration. However, R 3 and R 4 are not the same alkyl group at the same time. ), A compound represented by the formula [3]
【0012】[0012]
【化13】 (式中、R1、R3、R4及び*は前記と同じ意味を示
す。)で表される化合物の製造方法、および 2.式〔4〕Embedded image (Wherein R 1 , R 3 , R 4 and * have the same meanings as described above), and 1. Formula [4]
【0013】[0013]
【化14】 (式中、R5はニトロ基、アルキル基 またはフェニル
基を,R6は低級アルキル基を、R7は低級アルコキシカ
ルボニルメチル基を示し、*は前記と同一の意味を示
す。)で表される化合物である。Embedded image (In the formula, R 5 is a nitro group, an alkyl group or a phenyl group, R 6 is a lower alkyl group, R 7 is a lower alkoxycarbonylmethyl group, and * has the same meaning as described above.). Is a compound.
【0014】[0014]
【発明の実施の形態】本発明の製造方法は、式〔1〕で
表される化合物と式〔2〕で表される化合物とを通常不
活性溶媒中、パラジウム触媒存在下にカップリング反応
させることにより行われる。BEST MODE FOR CARRYING OUT THE INVENTION In the production method of the present invention, the compound represented by the formula [1] and the compound represented by the formula [2] are usually subjected to a coupling reaction in the presence of a palladium catalyst in an inert solvent. It is done by
【0015】[0015]
【化15】 (式中、R1 、R2 、R3 、R4 及び*は前記と同一の
意味を示す。)Embedded image (In the formula, R 1 , R 2 , R 3 , R 4 and * have the same meanings as described above.)
【0016】本発明において用いられるパラジウム触媒
としては、PdCl2、PdCl2(PPh3)2、PdCl
2(CH3CN)2、PdCl2(PhCN)2 、Pd(OAc)
2 、Pd(PPh3)4などが挙げられる。カップリング反
応は、例えばTHF、ジオキサン等のエ−テル類、トル
エン,DMF,HMPA、,N−メチルピロリドン等の
反応に不活性な溶媒中、0℃〜150℃、好ましくは2
0℃〜70℃の温度で行う。触媒の使用量は特に制限さ
れるものではないが、通常式〔1〕のスズ化合物1モル
に対して1〜1万分の1モル、好ましくは0.1〜0.
001モルの範囲内の量で使用することができる。反応
終了後は通常の後処理を行うことにより目的物を得るこ
とができる。上記反応により、目的とする式〔3〕の光
学活性ケトン誘導体は、通常50〜95%の光学純度で
得ることができる。本発明化合物の構造は、IR、NM
R、Mass等から決定した。The palladium catalyst used in the present invention includes PdCl 2 , PdCl 2 (PPh 3 ) 2 and PdCl.
2 (CH 3 CN) 2 , PdCl 2 (PhCN) 2 , Pd (OAc)
2 , Pd (PPh 3 ) 4 and the like. The coupling reaction is carried out in a solvent inert to the reaction, such as ethers such as THF and dioxane, toluene, DMF, HMPA, and N-methylpyrrolidone, preferably 0 ° C to 150 ° C, preferably 2 ° C.
It is carried out at a temperature of 0 ° C to 70 ° C. The amount of the catalyst used is not particularly limited, but is usually 1 to 1 / 10,000 mol, preferably 0.1 to 0.10 mol per mol of the tin compound of the formula [1].
It can be used in an amount within the range of 001 mol. After completion of the reaction, the desired product can be obtained by performing usual post-treatment. By the above reaction, the desired optically active ketone derivative of the formula [3] can be usually obtained with an optical purity of 50 to 95%. The structures of the compounds of the present invention are IR, NM
It was determined from R, Mass, etc.
【0017】〔実施例1〕(3R)−3−(4−ニトロ
ベンゾイル)酪酸メチルエステルの製造Example 1 Production of (3R) -3- (4-nitrobenzoyl) butyric acid methyl ester
【0018】[0018]
【化16】 Embedded image
【0019】ビス(トリフェニルホスフィン)パラジウ
ムジクロリド0.07gと(4−ニトロフェニル)トリ
ブチルスズ2.06gをTHF10mlに懸濁し、(2
R)−3−メトキシカルボニルー2ーメチルプロピオン
酸(光学純度95%)から誘導した酸クロリドの0.9
9gを加え、8時間還流した。放冷後、THFを減圧留
去し、フッ化カリウム水溶液を加え室温で30分間攪拌
した。クロロホルムを加え攪拌した後、セライト濾過
し、濾液をクロロホルム抽出した。飽和食塩水で洗浄
後、無水硫酸マグネシウムで乾燥し、濃縮後残渣をシリ
カゲルカラムクロマトグラフィ−(酢酸エチル:ヘキサ
ン=1:5)により精製し、油状の目的物を0.88g
得た。 NMR δ1.25ppm(d,3H),2.5(d
d,1H),3.0(dd,1H),3.65(s,3
H),3.9(m,1H),8.15(d,2H),
8.35(d,3H) HPLC 90%ee カラム:CHIRALPAK
AS(ダイセル化学) UV :254nm 移動層:エタノ−ル:ヘキサン=1:9 流速 :1ml/minBis (triphenylphosphine) palladium dichloride (0.07 g) and (4-nitrophenyl) tributyltin (2.06 g) were suspended in THF (10 ml) to prepare (2
R) -3-Methoxycarbonyl-2-methylpropionic acid (optical purity 95%) of acid chloride derived from 0.9
9 g was added and refluxed for 8 hours. After cooling, THF was distilled off under reduced pressure, an aqueous potassium fluoride solution was added, and the mixture was stirred at room temperature for 30 minutes. After adding chloroform and stirring, the mixture was filtered through Celite, and the filtrate was extracted with chloroform. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, concentrated, and the residue was purified by silica gel column chromatography (ethyl acetate: hexane = 1: 5) to give 0.88 g of the oily desired product.
Obtained. NMR δ1.25 ppm (d, 3H), 2.5 (d
d, 1H), 3.0 (dd, 1H), 3.65 (s, 3
H), 3.9 (m, 1H), 8.15 (d, 2H),
8.35 (d, 3H) HPLC 90% ee Column: CHIRALPAK
AS (Daicel chemistry) UV: 254 nm Moving layer: Ethanol: Hexane = 1: 9 Flow rate: 1 ml / min
【0020】〔参考例〕(2R)−3−メトキシカルボ
ニルー2ーメチルプロピオン酸クロリドの製造[Reference Example] Production of (2R) -3-methoxycarbonyl-2-methylpropionic acid chloride
【0021】[0021]
【化17】 Embedded image
【0022】(2R)−3−メトキシカルボニルー2ー
メチルプロピオン酸100gをジクロロメタン70ml
に溶解し、塩化チオニルを200g加えた。DMFを1
0滴加え1時間還流した。過剰の塩化チオニル及び溶媒
を減圧留去した後、減圧蒸留して目的物105.4g
(bp50−60℃/0.5−5mmHg)を得た。100 g of (2R) -3-methoxycarbonyl-2-methylpropionic acid was added to 70 ml of dichloromethane.
And was added to 200 g of thionyl chloride. 1 DMF
0 drop was added and the mixture was refluxed for 1 hour. After distilling off excess thionyl chloride and the solvent under reduced pressure, the residue was distilled under reduced pressure to obtain 105.4 g of the desired product.
(Bp 50-60 ° C./0.5-5 mmHg) was obtained.
【0023】[0023]
【発明の効果】本発明の製造方法によれば、光学活性ケ
トン誘導体を工業的に有利に製造できる。本発明光学活
性誘導体は、農医薬合成中間体として有用である。例え
ば、特開平2−56468及び特開平6−192098
に記載される強心作用又は血小板凝集抑制作用を有する
化合物の光学活性体を製造するための合成中間体として
有用である。According to the production method of the present invention, an optically active ketone derivative can be produced industrially advantageously. The optically active derivative of the present invention is useful as an intermediate for the synthesis of agricultural drugs. For example, JP-A-2-56468 and JP-A-6-192098.
It is useful as a synthetic intermediate for producing an optically active compound of the compound having a cardiotonic action or a platelet aggregation inhibitory action described in 1.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07C 49/84 9049−4H C07C 49/84 C 67/343 67/343 69/738 9546−4H 69/738 Z 201/12 201/12 205/56 205/56 319/20 319/20 323/62 323/62 // C07B 61/00 300 C07B 61/00 300 C07M 7:00 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication C07C 49/84 9049-4H C07C 49/84 C 67/343 67/343 69/738 9546-4H 69 / 738 Z 201/12 201/12 205/56 205/56 319/20 319/20 323/62 323/62 // C07B 61/00 300 C07B 61/00 300 C07M 7:00
Claims (2)
ルキル基、フェニル基、アルコキシ基又はアルキルチオ
基を、R2 は低級アルキル基又はハロゲン原子を示
す。)で表される化合物と、 式〔2〕 【化2】 (式中、R3 は低級アルキル基又はハロゲン原子を、R
4 は低級アルキル基又は低級アルコキシカルボニルメチ
ル基を示し、*を付した炭素原子は〔R〕−配置又は
〔S〕−配置を有する。但しR3 とR4 は同時に同じア
ルキル基ではない。)で表される化合物とを反応させる
ことを特徴とする、 式〔3〕 【化3】 (式中、R1、R3、R4及び*は前記と同じ意味を示
す。)で表される化合物の製造方法。1. A formula [1]: (Wherein R 1 represents a hydrogen atom, a halogen atom, a nitro group, an alkyl group, a phenyl group, an alkoxy group or an alkylthio group, and R 2 represents a lower alkyl group or a halogen atom); [2] [Chemical Formula 2] (In the formula, R 3 is a lower alkyl group or a halogen atom,
4 represents a lower alkyl group or a lower alkoxycarbonylmethyl group, and the carbon atom marked with * has [R] -configuration or [S] -configuration. However, R 3 and R 4 are not the same alkyl group at the same time. ), A compound represented by the formula [3]: (Wherein R 1 , R 3 , R 4 and * have the same meanings as described above).
基を,R6は低級アルキル基を、R7は低級アルコキシカ
ルボニルメチル基を示し、*を付した炭素原子は〔R〕
−配置又は〔S〕−配置を有する)で表される化合物2. A formula [4]: (In the formula, R 5 is a nitro group, an alkyl group or a phenyl group, R 6 is a lower alkyl group, R 7 is a lower alkoxycarbonylmethyl group, and the carbon atom with * is [R].
-Configuration or [S] -configuration)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7212862A JPH0940601A (en) | 1995-07-28 | 1995-07-28 | Method for producing optically active ketone derivative and optically active ketone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7212862A JPH0940601A (en) | 1995-07-28 | 1995-07-28 | Method for producing optically active ketone derivative and optically active ketone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0940601A true JPH0940601A (en) | 1997-02-10 |
Family
ID=16629535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7212862A Pending JPH0940601A (en) | 1995-07-28 | 1995-07-28 | Method for producing optically active ketone derivative and optically active ketone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0940601A (en) |
-
1995
- 1995-07-28 JP JP7212862A patent/JPH0940601A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4147516B2 (en) | Novel intermediate compound and method for producing optically active octanoic acid derivative | |
| JPH0940601A (en) | Method for producing optically active ketone derivative and optically active ketone derivative | |
| JPH09143173A (en) | Optically active 5,5-diphenyl-2-oxazolidinone derivative | |
| JP4701196B2 (en) | Silicon Lewis acid catalyst and reaction method using silicon Lewis acid catalyst | |
| EP1908747B1 (en) | Process for producing optically active 2-hydroxybutyric ester | |
| JP4147190B2 (en) | Process for producing β-ketoester compound | |
| JP6230528B2 (en) | Process for producing optically active 2-vinylcyclopropane-1,1-dicarboxylic acid ester | |
| JP3808931B2 (en) | Optically active 4,5-diphenyl-1,3-dialkyl-2-halogenoimidazolinium halogenide | |
| JP6158168B2 (en) | Process for producing optically active 2-vinylcyclopropane-1,1-dicarboxylic acid ester | |
| JPH09255641A (en) | Optically active phenyl ketone derivative and its production | |
| JP2000007664A (en) | Optically active piperazine compound, its intermediate and their production | |
| JP2579547B2 (en) | Preparation of alkoxycarbonyl compounds | |
| WO2000029369A1 (en) | Aminoacrylic acid derivatives and process for producing the same | |
| JP2652248B2 (en) | Process for producing alkoxynitrile compounds | |
| JPS61158962A (en) | Production of 1,4-dihydropyridine derivative | |
| JP4560309B2 (en) | Method for producing optically active amino acid derivative | |
| JP2765575B2 (en) | Process for producing substituted cyclopentenone and substituted cyclohexenone derivatives | |
| JP3013760B2 (en) | Method for producing 4-hydroxy-2-pyrrolidone | |
| JP2001247514A (en) | Method for producing α, α-difluoro-β-ketoester, method for producing difluoroketene silyl acetal, and method for producing optically active α, α-difluoro-β-hydroxyester | |
| JP3717343B2 (en) | Process for producing optically active Friedel-Craft reaction products | |
| JPH0847398A (en) | Process for producing optically active propargyl alcohol compound | |
| JP5773850B2 (en) | Method for producing optically active α-alkylserine derivative | |
| JP2000198775A (en) | Cyclic guanidine and its production | |
| JP2008247835A (en) | Process for producing β-diketone compound having methoxy group | |
| WO2000053575A1 (en) | SYNTHESIS OF α-AMINO-α',α'-DIHALOKETONES AND PROCESS FOR THE PREPARATION OF β-AMINO ACID DERIVATIVES BY THE USE OF THE SAME |